703 filings
Page 15 of 36
S-3MEF
y7di2sx
30 Jan 14
Registration of additional securities for an S-3
12:00am
424B5
sijl8r860u3y u1
30 Jan 14
Prospectus supplement for primary offering
12:00am
8-K
9zdoe9x1ku r6
30 Jan 14
Results of Operations and Financial Condition
12:00am
EFFECT
uqqzr2fppxxjkdqnq
9 Jan 14
Notice of effectiveness
12:00am
8-K
avggham vtpnv
6 Jan 14
Departure of Directors or Certain Officers
12:00am
EFFECT
txh56ct9bioy3 rsw
23 Dec 13
Notice of effectiveness
12:00am
8-K
gfln4 bxs
11 Dec 13
CytRx Reports Highly Statistically Significant Positive Results from its Global Phase 2b Clinical Trial
12:00am
8-K
0ezoznznu5znil95
29 Oct 13
CytRx Reports 2013 Third Quarter Financial Results
12:00am
424B2
oyb3en55skgraryd
10 Oct 13
Prospectus for primary offering
12:00am
8-K
mleqp3y9i35fz2
9 Oct 13
CytRx Announces Proposed Public Offering of Common Stock
12:00am
424B5
36b6n8bb6xe ds67
8 Oct 13
Prospectus supplement for primary offering
12:00am
8-K
z6d0n
6 Aug 13
CytRx Reports 2013 Second Quarter Financial Results
12:00am
8-K
fdvca45m96twst62rsb7
16 Jul 13
Amendments to Articles of Incorporation or Bylaws
12:00am
8-K
w0fd684f6 1b5eq
9 May 13
CytRx Reports 2013 First Quarter Financial Results
12:00am